Last $419.87 USD
Change Today -3.17 / -0.75%
Volume 691.0K
As of 8:10 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pindaros Roy Vagelos M.D.

Chairman and Member of Technology Committee, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 108 board members in 5 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Pindaros Roy Vagelos, M.D., served as the Chairman at Merck & Co. Inc., from April 1986 to November 1994 and its Chief Executive Officer from July 1985 to June 1994 also President since 1985. Dr. Vagelos joined Merck in 1975. He served as an Executive Vice President of the worldwide health products company and before that, President of its Research Division, which he joined in 1975. He served as Chairman of the Department of Biological Chemistry of the School of ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-847-7000
Fax: --

Board Members Memberships*

Chairman and Member of Technology Committee


Honorary Doctorate
Harvard University
Honorary Doctorate
University of Medicine and Dentistry of New Jersey
Honorary Doctorate
Columbia University
Honorary Doctorate
Rutgers, The State University of New Jersey
Honorary Doctorate
The University of Pennsylvania
The University of Pennsylvania
Honorary Doctorate
Brown University
Honorary Doctorate
New York University
Honorary Doctorate
Washington University, St. Louis
Honorary Doctorate
University Of British Columbia
Honorary Doctorate
New Jersey Institute Of Technology
New Jersey Institute Of Technology
Honorary Doctorate
Mount Sinai NYU Health
Honorary Doctorate
Princeton University
Columbia University College of Physicians & Surgeons in New York

Other Affiliations*

Annual Compensation*

Total Annual Compensation$100,000

Stock Options*

All Other Compensation$256,910

Total Compensation*

Total Annual Cash Compensation$356,910
Total Short Term Compensation$100,000
Other Long Term Compensation$256,910
Total Calculated Compensation$17,818,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $419.87 USD -3.17


Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Leonard Bell M.D.Co-Founder, Chairman of the Board and Chief Executive Officer
Alexion Pharmaceuticals, Inc.
Nobuo Hanai Ph.D.Chief Executive Officer, President and Representative Director
Kyowa Hakko Kirin Co., Ltd.
Jean-Christophe Tellier Chief Executive Officer and Director
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at